Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

NALOXONE HYDROCHLORIDE INTRANASAL SPRAY

Awarded
SPE2D226F2917Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Defense Logistics Agency award SPE2D226F2917 is a delivery order issued to DMS Pharmaceutical Group Inc for the procurement of Naloxone Hydrochloride Intranasal Spray. This order is placed under the broader base administrative contract SPE2DX-25-D-9822, which has a total award ceiling of 20,000,000.00 dollars. The specific delivery order consists of CLIN 0001 for 527 boxes at a unit price of 32.42 dollars. The acquisition was set aside for Women-Owned Small Businesses under NAICS code 325412. The delivery is scheduled for July 1, 2026, to the USNS Sojourner Truth in San Diego, California, with terms established as FOB Destination. Shipping must be conducted via the fastest traceable means, excluding parcel post. Items must be identifiable by National Drug Code and Manufacturer CAGE Code. The contract is governed by FAR Part 12 for commercial items, specifically incorporating clauses 52.212-1, 52.212-3, 52.212-4, and 52.212-5. Inspection and acceptance are the responsibility of the government upon arrival at the destination. Payment is handled by the Defense Finance and Accounting Service in Columbus, Ohio, under Fast Pay Net 15 discount terms.

General Info

DLA awarded DMS Pharmaceutical Group Naloxone spray for USNS Sojourner Truth by 2026.

Contract Value

$32.42

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

IL, USA

Set-Aside

NONE

Award Issued Date

Documents

2

SPE2D226F2917 - Naloxone Hydrochloride Intranasal Spray

PDF, High priority: read this firstaward
High

SPE2DX-25-D-9822 - DMS Pharmaceutical Group Inc

PDF, High priority: read this firstaward
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2D226F2917 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $32.42 Award Date: 07-01-2026 Delivery order under: SPE2DX25D9822 Line items: - NALOXONE HYDROCHLORIDE INTRANASAL SPRAY (NSN/Part 6505016582463, PR 7017368465)

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS